Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 7.69951230 |
2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.40602573 |
3 | pantothenate metabolic process (GO:0015939) | 7.04968152 |
4 | macrophage chemotaxis (GO:0048246) | 6.65633386 |
5 | coenzyme A biosynthetic process (GO:0015937) | 6.55771215 |
6 | epoxygenase P450 pathway (GO:0019373) | 6.42030833 |
7 | NADH metabolic process (GO:0006734) | 6.13304830 |
8 | * bile acid and bile salt transport (GO:0015721) | 6.09649039 |
9 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 6.09430899 |
10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.78467410 |
11 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.57356098 |
12 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.43181480 |
13 | desmosome organization (GO:0002934) | 5.39553075 |
14 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 5.32133170 |
15 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 5.32133170 |
16 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 5.32133170 |
17 | lymphocyte chemotaxis (GO:0048247) | 5.24969573 |
18 | plasma lipoprotein particle assembly (GO:0034377) | 5.17032559 |
19 | drug metabolic process (GO:0017144) | 5.05025939 |
20 | urea cycle (GO:0000050) | 4.95074488 |
21 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.88338565 |
22 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.88338565 |
23 | endocrine process (GO:0050886) | 4.88338565 |
24 | glycosylceramide metabolic process (GO:0006677) | 4.88324393 |
25 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.83771002 |
26 | urea metabolic process (GO:0019627) | 4.79385878 |
27 | neurotransmitter biosynthetic process (GO:0042136) | 4.77271117 |
28 | vitamin transmembrane transport (GO:0035461) | 4.72752252 |
29 | fructose metabolic process (GO:0006000) | 4.69727826 |
30 | regulation of cholesterol esterification (GO:0010872) | 4.65755300 |
31 | hormone catabolic process (GO:0042447) | 4.65103432 |
32 | protein-lipid complex assembly (GO:0065005) | 4.64510594 |
33 | intestinal absorption (GO:0050892) | 4.61141601 |
34 | negative regulation of DNA repair (GO:0045738) | 4.60277637 |
35 | phosphatidylcholine biosynthetic process (GO:0006656) | 4.60155350 |
36 | high-density lipoprotein particle remodeling (GO:0034375) | 4.59566256 |
37 | negative regulation of receptor activity (GO:2000272) | 4.54137434 |
38 | neurotransmitter metabolic process (GO:0042133) | 4.46293736 |
39 | nitrogen cycle metabolic process (GO:0071941) | 4.40723387 |
40 | positive regulation of interleukin-1 secretion (GO:0050716) | 4.37205632 |
41 | epithelial structure maintenance (GO:0010669) | 4.35944473 |
42 | diacylglycerol metabolic process (GO:0046339) | 4.34371660 |
43 | regulation of systemic arterial blood pressure (GO:0003073) | 4.28712604 |
44 | coenzyme A metabolic process (GO:0015936) | 4.25492687 |
45 | regulation of cGMP biosynthetic process (GO:0030826) | 4.16712436 |
46 | protein-lipid complex remodeling (GO:0034368) | 4.15717957 |
47 | macromolecular complex remodeling (GO:0034367) | 4.15717957 |
48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.15717957 |
49 | striated muscle atrophy (GO:0014891) | 4.06323038 |
50 | reverse cholesterol transport (GO:0043691) | 4.04736390 |
51 | regulation of interleukin-1 secretion (GO:0050704) | 4.04356432 |
52 | lipoprotein metabolic process (GO:0042157) | 4.03003834 |
53 | renal system process involved in regulation of blood volume (GO:0001977) | 4.01297071 |
54 | thrombin receptor signaling pathway (GO:0070493) | 3.98247726 |
55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.97360856 |
56 | intestinal cholesterol absorption (GO:0030299) | 3.95346512 |
57 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.92030748 |
58 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.89338636 |
59 | sulfur amino acid catabolic process (GO:0000098) | 3.87122548 |
60 | response to hydroperoxide (GO:0033194) | 3.85576019 |
61 | regulation of bile acid biosynthetic process (GO:0070857) | 3.84525191 |
62 | oligosaccharide biosynthetic process (GO:0009312) | 3.84392988 |
63 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.83368162 |
64 | bile acid metabolic process (GO:0008206) | 3.80968773 |
65 | flavonoid metabolic process (GO:0009812) | 3.79729155 |
66 | drug transmembrane transport (GO:0006855) | 3.79379466 |
67 | digestion (GO:0007586) | 3.78016064 |
68 | positive regulation of lipid catabolic process (GO:0050996) | 3.77948807 |
69 | cholesterol efflux (GO:0033344) | 3.77552681 |
70 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.77043795 |
71 | plasma lipoprotein particle organization (GO:0071827) | 3.76288787 |
72 | angiotensin maturation (GO:0002003) | 3.74911663 |
73 | arginine metabolic process (GO:0006525) | 3.73582766 |
74 | drug catabolic process (GO:0042737) | 3.73291136 |
75 | alkaloid metabolic process (GO:0009820) | 3.71365867 |
76 | regulation of guanylate cyclase activity (GO:0031282) | 3.71167933 |
77 | ethanol oxidation (GO:0006069) | 3.67584288 |
78 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.66718611 |
79 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.66718611 |
80 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.66718611 |
81 | renal absorption (GO:0070293) | 3.62757761 |
82 | artery development (GO:0060840) | 3.62267936 |
83 | regulation of cellular extravasation (GO:0002691) | 3.60473582 |
84 | skeletal muscle adaptation (GO:0043501) | 3.58678414 |
85 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.57701439 |
86 | phosphate ion transmembrane transport (GO:0035435) | 3.57559780 |
87 | cellular glucuronidation (GO:0052695) | 3.57037103 |
88 | protein-lipid complex subunit organization (GO:0071825) | 3.56170367 |
89 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54082329 |
90 | exogenous drug catabolic process (GO:0042738) | 3.52637578 |
91 | regulation of vitamin metabolic process (GO:0030656) | 3.50976213 |
92 | adhesion of symbiont to host cell (GO:0044650) | 3.50358268 |
93 | virion attachment to host cell (GO:0019062) | 3.50358268 |
94 | vitamin A metabolic process (GO:0006776) | 3.49155489 |
95 | antibacterial humoral response (GO:0019731) | 3.47579074 |
96 | peptide hormone processing (GO:0016486) | 3.46985543 |
97 | regulation of metalloenzyme activity (GO:0048552) | 3.46276300 |
98 | cellular ketone body metabolic process (GO:0046950) | 3.45836139 |
99 | sulfur compound transport (GO:0072348) | 3.44125090 |
100 | fat-soluble vitamin metabolic process (GO:0006775) | 3.44112289 |
101 | lipoprotein transport (GO:0042953) | 3.42491277 |
102 | regulation of cGMP metabolic process (GO:0030823) | 3.41934117 |
103 | oligosaccharide catabolic process (GO:0009313) | 3.41751692 |
104 | L-ascorbic acid metabolic process (GO:0019852) | 3.40810403 |
105 | regulation of cholesterol homeostasis (GO:2000188) | 3.39365730 |
106 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.37718699 |
107 | vitamin biosynthetic process (GO:0009110) | 3.37343316 |
108 | acute-phase response (GO:0006953) | 3.36246416 |
109 | glycolipid catabolic process (GO:0019377) | 3.35043077 |
110 | regulation of triglyceride catabolic process (GO:0010896) | 3.34474566 |
111 | phosphate ion transport (GO:0006817) | 3.34427736 |
112 | modified amino acid transport (GO:0072337) | 3.34100430 |
113 | glycosphingolipid biosynthetic process (GO:0006688) | 3.33891227 |
114 | nitric oxide biosynthetic process (GO:0006809) | 3.33204672 |
115 | glycosphingolipid catabolic process (GO:0046479) | 3.32894207 |
116 | proline metabolic process (GO:0006560) | 3.32526324 |
117 | antimicrobial humoral response (GO:0019730) | 3.32404784 |
118 | sulfate transport (GO:0008272) | 3.32039575 |
119 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.31155481 |
120 | drinking behavior (GO:0042756) | 3.29701482 |
121 | muscle atrophy (GO:0014889) | 3.28983160 |
122 | drug transport (GO:0015893) | 3.28380805 |
123 | homocysteine metabolic process (GO:0050667) | 3.25764221 |
124 | positive regulation of respiratory burst (GO:0060267) | 3.25196427 |
125 | phenylpropanoid metabolic process (GO:0009698) | 3.24327156 |
126 | regulation of RIG-I signaling pathway (GO:0039535) | 3.24196014 |
127 | negative regulation of cholesterol transport (GO:0032375) | 3.23244505 |
128 | negative regulation of sterol transport (GO:0032372) | 3.23244505 |
129 | positive regulation of pseudopodium assembly (GO:0031274) | 3.23204242 |
130 | transepithelial transport (GO:0070633) | 3.22508246 |
131 | glucuronate metabolic process (GO:0019585) | 3.22257423 |
132 | uronic acid metabolic process (GO:0006063) | 3.22257423 |
133 | actin filament depolymerization (GO:0030042) | 3.18883581 |
134 | glycerol metabolic process (GO:0006071) | 3.17929871 |
135 | vitamin transport (GO:0051180) | 3.15186948 |
136 | low-density lipoprotein particle remodeling (GO:0034374) | 3.14811347 |
137 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.14233521 |
138 | adhesion of symbiont to host (GO:0044406) | 3.13526133 |
139 | sodium ion homeostasis (GO:0055078) | 3.13240046 |
140 | cholesterol homeostasis (GO:0042632) | 3.12486528 |
141 | digestive system process (GO:0022600) | 3.10496381 |
142 | midgut development (GO:0007494) | 3.10480106 |
143 | sterol homeostasis (GO:0055092) | 3.09951840 |
144 | peptide catabolic process (GO:0043171) | 3.09533335 |
145 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.09518823 |
146 | cytidine deamination (GO:0009972) | 3.09321428 |
147 | cytidine metabolic process (GO:0046087) | 3.09321428 |
148 | cytidine catabolic process (GO:0006216) | 3.09321428 |
149 | urate metabolic process (GO:0046415) | 3.09089120 |
150 | ganglioside metabolic process (GO:0001573) | 3.07366830 |
151 | positive regulation of interleukin-1 production (GO:0032732) | 3.06018909 |
152 | phospholipid efflux (GO:0033700) | 3.03322491 |
153 | alditol metabolic process (GO:0019400) | 3.01689373 |
154 | cysteine metabolic process (GO:0006534) | 2.99148003 |
155 | ketone body metabolic process (GO:1902224) | 2.98263006 |
156 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.96189721 |
157 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.96189721 |
158 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.94141946 |
159 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.94141946 |
160 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.93468149 |
161 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.92114199 |
162 | sulfate transmembrane transport (GO:1902358) | 2.86926411 |
163 | tryptophan catabolic process (GO:0006569) | 2.86227576 |
164 | indole-containing compound catabolic process (GO:0042436) | 2.86227576 |
165 | indolalkylamine catabolic process (GO:0046218) | 2.86227576 |
166 | regulation of histone phosphorylation (GO:0033127) | 2.82218939 |
167 | lysine catabolic process (GO:0006554) | 2.80955140 |
168 | lysine metabolic process (GO:0006553) | 2.80955140 |
169 | lymphocyte migration (GO:0072676) | 2.79788124 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.74391709 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.17987277 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.44856405 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.23372000 |
5 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.21644199 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13884410 |
7 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.00117551 |
8 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.71836651 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71365810 |
10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.61427866 |
11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45338903 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.45068306 |
13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38485532 |
14 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.30956651 |
15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.26238447 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.25736777 |
17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.12038045 |
18 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.00566898 |
19 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91679467 |
20 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.86843576 |
21 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.85505986 |
22 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84017032 |
23 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.82225052 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.81877419 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.81583862 |
26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72056633 |
27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71673259 |
28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71200594 |
29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66263634 |
30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65240587 |
31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64733129 |
32 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63611488 |
33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.63290895 |
34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61357335 |
35 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60517125 |
36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60084162 |
37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59555206 |
38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59296601 |
39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56097898 |
40 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.54069766 |
41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.52464344 |
42 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46735449 |
43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.45566247 |
44 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.43190361 |
45 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.38573568 |
46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36419046 |
47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.32796879 |
48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28659654 |
49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27051147 |
50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26201653 |
51 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25872948 |
52 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.20666278 |
53 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20016736 |
54 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.19099292 |
55 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.18916515 |
56 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14170663 |
57 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13277126 |
58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12954278 |
59 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.12594883 |
60 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11868459 |
61 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11745063 |
62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.10127364 |
63 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.09866453 |
64 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.08912044 |
65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08400649 |
66 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07944096 |
67 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07925246 |
68 | RXR_22108803_ChIP-Seq_LS180_Human | 1.06965718 |
69 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06193799 |
70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06117685 |
71 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05577589 |
72 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03124133 |
73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02771579 |
74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01203432 |
75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00893693 |
76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98035300 |
77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98021673 |
78 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96780358 |
79 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96250932 |
80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94689114 |
81 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94658430 |
82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93866244 |
83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92857017 |
84 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92177106 |
85 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92168248 |
86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92081570 |
87 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91653242 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91187707 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90431229 |
90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90251040 |
91 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89421600 |
92 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.89271571 |
93 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89266463 |
94 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.89262500 |
95 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88760267 |
96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88678370 |
97 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.88339189 |
98 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.87307974 |
99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86687567 |
100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.86612042 |
101 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86561605 |
102 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86188285 |
103 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86117549 |
104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85665785 |
105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85403442 |
106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85088303 |
107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84979864 |
108 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84609848 |
109 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.84509923 |
110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83380597 |
111 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.83291659 |
112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.83185237 |
113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82701295 |
114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82216741 |
115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82015084 |
116 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81532455 |
117 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81284129 |
118 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.80882343 |
119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80781975 |
120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80123552 |
121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80040160 |
122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79496451 |
123 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77719994 |
124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77535095 |
125 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.77318651 |
126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76925408 |
127 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.76699801 |
128 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76383224 |
129 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.75981576 |
130 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.75834611 |
131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75812017 |
132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75549120 |
133 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75288462 |
134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74984144 |
135 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.74605178 |
136 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74234703 |
137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74080656 |
138 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.73078659 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 6.24064128 |
2 | MP0002822_catalepsy | 4.58160977 |
3 | MP0005377_hearing/vestibular/ear_phenot | 3.86360503 |
4 | MP0003878_abnormal_ear_physiology | 3.86360503 |
5 | MP0003183_abnormal_peptide_metabolism | 3.44867696 |
6 | MP0002139_abnormal_hepatobiliary_system | 3.44180329 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.96805085 |
8 | MP0004147_increased_porphyrin_level | 2.96530439 |
9 | MP0005085_abnormal_gallbladder_physiolo | 2.80624428 |
10 | MP0003283_abnormal_digestive_organ | 2.70269602 |
11 | MP0001666_abnormal_nutrient_absorption | 2.62554692 |
12 | MP0009379_abnormal_foot_pigmentation | 2.57640633 |
13 | MP0005167_abnormal_blood-brain_barrier | 2.35590786 |
14 | MP0004264_abnormal_extraembryonic_tissu | 2.34839601 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.30089431 |
16 | MP0003252_abnormal_bile_duct | 2.18235956 |
17 | MP0005257_abnormal_intraocular_pressure | 2.17163052 |
18 | MP0010234_abnormal_vibrissa_follicle | 11.0447939 |
19 | MP0010678_abnormal_skin_adnexa | 1.97334037 |
20 | MP0004019_abnormal_vitamin_homeostasis | 1.97172777 |
21 | MP0002876_abnormal_thyroid_physiology | 1.85547494 |
22 | MP0005365_abnormal_bile_salt | 1.85214743 |
23 | MP0000604_amyloidosis | 1.76474258 |
24 | MP0009643_abnormal_urine_homeostasis | 1.75762411 |
25 | MP0010329_abnormal_lipoprotein_level | 1.69448549 |
26 | MP0004043_abnormal_pH_regulation | 1.66656884 |
27 | MP0005409_darkened_coat_color | 1.66206808 |
28 | MP0005058_abnormal_lysosome_morphology | 1.63280701 |
29 | MP0003866_abnormal_defecation | 1.61908974 |
30 | MP0001764_abnormal_homeostasis | 1.58262428 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.56723735 |
32 | MP0005332_abnormal_amino_acid | 1.52747094 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.50201635 |
34 | MP0000013_abnormal_adipose_tissue | 1.47652104 |
35 | MP0002796_impaired_skin_barrier | 1.41196217 |
36 | MP0004185_abnormal_adipocyte_glucose | 1.33957151 |
37 | MP0003718_maternal_effect | 1.30003184 |
38 | MP0000462_abnormal_digestive_system | 1.27819075 |
39 | MP0005310_abnormal_salivary_gland | 1.14807809 |
40 | MP0001765_abnormal_ion_homeostasis | 1.13829712 |
41 | MP0005636_abnormal_mineral_homeostasis | 1.10530714 |
42 | MP0009840_abnormal_foam_cell | 1.10239522 |
43 | MP0000678_abnormal_parathyroid_gland | 1.09896917 |
44 | MP0002138_abnormal_hepatobiliary_system | 1.09112110 |
45 | MP0005319_abnormal_enzyme/_coenzyme | 1.09024352 |
46 | MP0002118_abnormal_lipid_homeostasis | 1.08839490 |
47 | MP0000477_abnormal_intestine_morphology | 1.07755448 |
48 | MP0005670_abnormal_white_adipose | 1.06083027 |
49 | MP0004947_skin_inflammation | 1.05956641 |
50 | MP0005076_abnormal_cell_differentiation | 1.02142139 |
51 | MP0001664_abnormal_digestion | 1.01676094 |
52 | MP0005448_abnormal_energy_balance | 0.98755029 |
53 | MP0002098_abnormal_vibrissa_morphology | 0.98342597 |
54 | MP0001663_abnormal_digestive_system | 0.97751317 |
55 | MP0003045_fibrosis | 0.97169672 |
56 | MP0005084_abnormal_gallbladder_morpholo | 0.96917685 |
57 | MP0001873_stomach_inflammation | 0.95185739 |
58 | MP0010155_abnormal_intestine_physiology | 0.93975053 |
59 | MP0005381_digestive/alimentary_phenotyp | 0.93843076 |
60 | MP0003453_abnormal_keratinocyte_physiol | 0.91851324 |
61 | MP0008872_abnormal_physiological_respon | 0.91543948 |
62 | MP0010352_gastrointestinal_tract_polyps | 0.90149941 |
63 | MP0000490_abnormal_crypts_of | 0.89316880 |
64 | MP0001188_hyperpigmentation | 0.88206189 |
65 | MP0001216_abnormal_epidermal_layer | 0.87505818 |
66 | MP0003300_gastrointestinal_ulcer | 0.86536255 |
67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.86472790 |
68 | MP0002909_abnormal_adrenal_gland | 0.86470068 |
69 | MP0009785_altered_susceptibility_to | 0.85350554 |
70 | MP0002136_abnormal_kidney_physiology | 0.84635354 |
71 | MP0001756_abnormal_urination | 0.84557254 |
72 | MP0000383_abnormal_hair_follicle | 0.80287418 |
73 | MP0000538_abnormal_urinary_bladder | 0.77826096 |
74 | MP0009115_abnormal_fat_cell | 0.77114577 |
75 | MP0005535_abnormal_body_temperature | 0.76718632 |
76 | MP0000377_abnormal_hair_follicle | 0.75435053 |
77 | MP0000427_abnormal_hair_cycle | 0.73580011 |
78 | MP0001501_abnormal_sleep_pattern | 0.73098691 |
79 | MP0005451_abnormal_body_composition | 0.72771162 |
80 | MP0008873_increased_physiological_sensi | 0.72668446 |
81 | MP0002971_abnormal_brown_adipose | 0.71715289 |
82 | MP0003195_calcinosis | 0.70740208 |
83 | MP0000566_synostosis | 0.69677408 |
84 | MP0001485_abnormal_pinna_reflex | 0.69600474 |
85 | MP0003329_amyloid_beta_deposits | 0.69204863 |
86 | MP0005666_abnormal_adipose_tissue | 0.68693859 |
87 | MP0003868_abnormal_feces_composition | 0.68059744 |
88 | MP0000609_abnormal_liver_physiology | 0.67852354 |
89 | MP0001845_abnormal_inflammatory_respons | 0.66393796 |
90 | MP0001849_ear_inflammation | 0.66275079 |
91 | MP0005501_abnormal_skin_physiology | 0.64365934 |
92 | MP0004858_abnormal_nervous_system | 0.62763987 |
93 | MP0003953_abnormal_hormone_level | 0.61965305 |
94 | MP0002148_abnormal_hypersensitivity_rea | 0.61538320 |
95 | MP0009053_abnormal_anal_canal | 0.59688327 |
96 | MP0000249_abnormal_blood_vessel | 0.59091279 |
97 | MP0003315_abnormal_perineum_morphology | 0.57611915 |
98 | MP0004782_abnormal_surfactant_physiolog | 0.56413648 |
99 | MP0002078_abnormal_glucose_homeostasis | 0.56283647 |
100 | MP0009642_abnormal_blood_homeostasis | 0.56032333 |
101 | MP0004270_analgesia | 0.55177619 |
102 | MP0003638_abnormal_response/metabolism_ | 0.54433671 |
103 | MP0003724_increased_susceptibility_to | 0.54398627 |
104 | MP0009697_abnormal_copulation | 0.53827433 |
105 | MP0003075_altered_response_to | 0.52667777 |
106 | MP0002089_abnormal_postnatal_growth/wei | 0.49286403 |
107 | MP0005395_other_phenotype | 0.48084327 |
108 | MP0005083_abnormal_biliary_tract | 0.47556506 |
109 | MP0004272_abnormal_basement_membrane | 0.46814562 |
110 | MP0002166_altered_tumor_susceptibility | 0.46220680 |
111 | MP0004885_abnormal_endolymph | 0.45612143 |
112 | MP0009931_abnormal_skin_appearance | 0.44874365 |
113 | MP0000537_abnormal_urethra_morphology | 0.44712497 |
114 | MP0000762_abnormal_tongue_morphology | 0.43696868 |
115 | MP0005165_increased_susceptibility_to | 0.43321545 |
116 | MP0005376_homeostasis/metabolism_phenot | 0.43148016 |
117 | MP0000516_abnormal_urinary_system | 0.43128961 |
118 | MP0005367_renal/urinary_system_phenotyp | 0.43128961 |
119 | MP0003879_abnormal_hair_cell | 0.42611010 |
120 | MP0005166_decreased_susceptibility_to | 0.42401734 |
121 | MP0008469_abnormal_protein_level | 0.42401027 |
122 | MP0005334_abnormal_fat_pad | 0.42069649 |
123 | MP0000230_abnormal_systemic_arterial | 0.41879158 |
124 | MP0000598_abnormal_liver_morphology | 0.41691539 |
125 | MP0002234_abnormal_pharynx_morphology | 0.40805142 |
126 | MP0001243_abnormal_dermal_layer | 0.40007733 |
127 | MP0002896_abnormal_bone_mineralization | 0.37637177 |
128 | MP0005025_abnormal_response_to | 0.37475553 |
129 | MP0010030_abnormal_orbit_morphology | 0.37389870 |
130 | MP0003941_abnormal_skin_development | 0.37362683 |
131 | MP0006082_CNS_inflammation | 0.36068409 |
132 | MP0009764_decreased_sensitivity_to | 0.35969665 |
133 | MP0002069_abnormal_eating/drinking_beha | 0.35058441 |
134 | MP0005408_hypopigmentation | 0.33631535 |
135 | MP0000465_gastrointestinal_hemorrhage | 0.33293606 |
136 | MP0002135_abnormal_kidney_morphology | 0.31686021 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of small intestinal villus morphology (HP:0011472) | 6.01205639 |
2 | Villous atrophy (HP:0011473) | 6.01205639 |
3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.22858307 |
4 | Malnutrition (HP:0004395) | 5.16065728 |
5 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.89459012 |
6 | Abnormality of vitamin B metabolism (HP:0004340) | 4.58841045 |
7 | Acanthocytosis (HP:0001927) | 4.40597343 |
8 | Pili torti (HP:0003777) | 4.32138507 |
9 | Decreased circulating renin level (HP:0003351) | 4.26138537 |
10 | Ileus (HP:0002595) | 4.23483752 |
11 | Chronic diarrhea (HP:0002028) | 4.05234960 |
12 | Abnormality of vitamin metabolism (HP:0100508) | 3.97047656 |
13 | Systemic lupus erythematosus (HP:0002725) | 3.93457786 |
14 | Right ventricular cardiomyopathy (HP:0011663) | 3.91234615 |
15 | Pigmentary retinal degeneration (HP:0001146) | 3.84021125 |
16 | Flat acetabular roof (HP:0003180) | 3.82681139 |
17 | Hyperactive renin-angiotensin system (HP:0000841) | 3.79836604 |
18 | Metabolic alkalosis (HP:0200114) | 3.77456677 |
19 | Nausea (HP:0002018) | 3.75136569 |
20 | Prostate neoplasm (HP:0100787) | 3.69211619 |
21 | Increased purine levels (HP:0004368) | 3.69165789 |
22 | Hyperuricemia (HP:0002149) | 3.69165789 |
23 | Cupped ribs (HP:0000887) | 3.66182384 |
24 | Abnormality of purine metabolism (HP:0004352) | 3.56856331 |
25 | Xanthomatosis (HP:0000991) | 3.44776932 |
26 | Intrahepatic cholestasis (HP:0001406) | 3.35429587 |
27 | Gout (HP:0001997) | 3.31850654 |
28 | Congenital sensorineural hearing impairment (HP:0008527) | 3.11889661 |
29 | Vacuolated lymphocytes (HP:0001922) | 3.05312849 |
30 | Hyperglycinuria (HP:0003108) | 3.01361830 |
31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.00528059 |
32 | Pustule (HP:0200039) | 2.97637557 |
33 | Wide cranial sutures (HP:0010537) | 2.95990375 |
34 | Hydroxyprolinuria (HP:0003080) | 2.95273461 |
35 | Abnormality of proline metabolism (HP:0010907) | 2.95273461 |
36 | Oligomenorrhea (HP:0000876) | 2.93527833 |
37 | Progressive sensorineural hearing impairment (HP:0000408) | 2.92888293 |
38 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.91156134 |
39 | Steatorrhea (HP:0002570) | 2.87108182 |
40 | Proximal tubulopathy (HP:0000114) | 2.80399694 |
41 | Abnormality of carpal bone ossification (HP:0006257) | 2.78960953 |
42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.77932189 |
43 | Hypoalphalipoproteinemia (HP:0003233) | 2.77431048 |
44 | Abnormality of chloride homeostasis (HP:0011422) | 2.77092904 |
45 | Hemorrhage of the eye (HP:0011885) | 2.76040212 |
46 | Facial shape deformation (HP:0011334) | 2.74540292 |
47 | Potter facies (HP:0002009) | 2.74540292 |
48 | Thin bony cortex (HP:0002753) | 2.74419639 |
49 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.74334569 |
50 | Increased circulating renin level (HP:0000848) | 2.74078103 |
51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.71516850 |
52 | Metabolic acidosis (HP:0001942) | 2.65627559 |
53 | Hypolipoproteinemia (HP:0010981) | 2.64006536 |
54 | Abnormality of the 1st metacarpal (HP:0010009) | 2.63330576 |
55 | Abnormal tarsal ossification (HP:0008369) | 2.59260221 |
56 | Arterial tortuosity (HP:0005116) | 2.57793942 |
57 | Epidermoid cyst (HP:0200040) | 2.56204077 |
58 | Hypophosphatemia (HP:0002148) | 2.56182622 |
59 | Abdominal distention (HP:0003270) | 2.54751997 |
60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53762433 |
61 | Abnormal urine phosphate concentration (HP:0012599) | 2.53404628 |
62 | Fat malabsorption (HP:0002630) | 2.52529331 |
63 | Abnormal hair laboratory examination (HP:0003328) | 2.51929485 |
64 | Widely patent fontanelles and sutures (HP:0004492) | 2.50585883 |
65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.49408244 |
66 | Alkalosis (HP:0001948) | 2.47832407 |
67 | Megaloblastic anemia (HP:0001889) | 2.47550236 |
68 | Dehydration (HP:0001944) | 2.47449052 |
69 | Hypomagnesemia (HP:0002917) | 2.46649434 |
70 | Hypobetalipoproteinemia (HP:0003563) | 2.46115092 |
71 | Abnormality of renin-angiotensin system (HP:0000847) | 2.45532726 |
72 | Hyperlipoproteinemia (HP:0010980) | 2.45466666 |
73 | Hyperphosphaturia (HP:0003109) | 2.44683782 |
74 | Delayed epiphyseal ossification (HP:0002663) | 2.43484168 |
75 | Hypokalemic alkalosis (HP:0001949) | 2.43020267 |
76 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.42057354 |
77 | Progressive hearing impairment (HP:0001730) | 2.40236920 |
78 | Complement deficiency (HP:0004431) | 2.39616024 |
79 | Esophageal varix (HP:0002040) | 2.39102449 |
80 | Hypotension (HP:0002615) | 2.37581891 |
81 | Generalized aminoaciduria (HP:0002909) | 2.34559252 |
82 | Abnormality of magnesium homeostasis (HP:0004921) | 2.33813541 |
83 | Vascular tortuosity (HP:0004948) | 2.31570217 |
84 | Hoarse voice (HP:0001609) | 2.30804192 |
85 | Abnormality of glycine metabolism (HP:0010895) | 2.30708851 |
86 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.30708851 |
87 | Abnormality of the costochondral junction (HP:0000919) | 2.30652076 |
88 | Posterior subcapsular cataract (HP:0007787) | 2.30537450 |
89 | Glomerulonephritis (HP:0000099) | 2.30336299 |
90 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.29802605 |
91 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.27585276 |
92 | Glycosuria (HP:0003076) | 2.25519734 |
93 | Abnormality of urine glucose concentration (HP:0011016) | 2.25519734 |
94 | Nephrolithiasis (HP:0000787) | 2.24481619 |
95 | Hypoglycemic coma (HP:0001325) | 2.21888639 |
96 | Focal segmental glomerulosclerosis (HP:0000097) | 2.20734589 |
97 | Neonatal short-limb short stature (HP:0008921) | 2.20596854 |
98 | Hyperaldosteronism (HP:0000859) | 2.20545733 |
99 | Abnormality of complement system (HP:0005339) | 2.18124160 |
100 | Axonal loss (HP:0003447) | 2.17215518 |
101 | Biliary tract neoplasm (HP:0100574) | 2.16278870 |
102 | Hyperglycinemia (HP:0002154) | 2.16222913 |
103 | Enlarged epiphyses (HP:0010580) | 2.16199074 |
104 | Renal tubular acidosis (HP:0001947) | 2.15724160 |
105 | Curly hair (HP:0002212) | 2.14664910 |
106 | Colitis (HP:0002583) | 2.13755573 |
107 | Poikilocytosis (HP:0004447) | 2.12231901 |
108 | Abnormality of the 2nd finger (HP:0004100) | 2.11311539 |
109 | Hypokalemia (HP:0002900) | 2.10553982 |
110 | Abnormal ossification of hand bones (HP:0005921) | 2.09954642 |
111 | Abnormal urine output (HP:0012590) | 2.08499065 |
112 | Goiter (HP:0000853) | 2.07934669 |
113 | Abnormal hand bone ossification (HP:0010660) | 2.04581648 |
114 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.04218870 |
115 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.03820035 |
116 | Pancreatitis (HP:0001733) | 2.03613473 |
117 | Sensorimotor neuropathy (HP:0007141) | 2.03368314 |
118 | Deep venous thrombosis (HP:0002625) | 2.02377218 |
119 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.01937005 |
120 | Hyperparathyroidism (HP:0000843) | 2.01706234 |
121 | Cerebral palsy (HP:0100021) | 2.00944982 |
122 | Late onset (HP:0003584) | 2.00412056 |
123 | Abnormality of potassium homeostasis (HP:0011042) | 1.99867179 |
124 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.99436430 |
125 | Myopathic facies (HP:0002058) | 1.96909250 |
126 | Irritability (HP:0000737) | 1.96241160 |
127 | Hyperammonemia (HP:0001987) | 1.95951389 |
128 | Abnormality of renal excretion (HP:0011036) | 1.95111032 |
129 | Subcapsular cataract (HP:0000523) | 1.94753604 |
130 | Hypercholesterolemia (HP:0003124) | 1.94513317 |
131 | Renal tubular dysfunction (HP:0000124) | 1.93510184 |
132 | Lethargy (HP:0001254) | 1.92768704 |
133 | Ketoacidosis (HP:0001993) | 1.91711411 |
134 | Nephritis (HP:0000123) | 1.88455696 |
135 | Metaphyseal irregularity (HP:0003025) | 1.86295261 |
136 | Ventricular tachycardia (HP:0004756) | 1.85931019 |
137 | Confusion (HP:0001289) | 1.85858300 |
138 | Tetany (HP:0001281) | 1.85007680 |
139 | Dicarboxylic aciduria (HP:0003215) | 1.84610276 |
140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84610276 |
141 | Visceral angiomatosis (HP:0100761) | 1.84563272 |
142 | Neoplasm of the small intestine (HP:0100833) | 1.83950060 |
143 | Conjugated hyperbilirubinemia (HP:0002908) | 1.83768474 |
144 | Protuberant abdomen (HP:0001538) | 1.83404385 |
145 | Abnormal cartilage morphology (HP:0002763) | 1.83379907 |
146 | Vascular calcification (HP:0004934) | 1.82026249 |
147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.80411043 |
148 | Glomerulosclerosis (HP:0000096) | 1.80059557 |
149 | Toxemia of pregnancy (HP:0100603) | 1.79600948 |
150 | Palpitations (HP:0001962) | 1.78292763 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PIK3CA | 9.21117597 |
2 | ACVR1B | 8.72488624 |
3 | MST1R | 8.24023421 |
4 | RIPK1 | 4.76964167 |
5 | FRK | 4.22985310 |
6 | MAP3K2 | 3.56088791 |
7 | MAP2K2 | 3.26587434 |
8 | KSR2 | 3.21338022 |
9 | MET | 2.97517110 |
10 | NME1 | 2.21397825 |
11 | TNIK | 1.93142848 |
12 | MAP3K14 | 1.57029652 |
13 | RIPK4 | 1.54960017 |
14 | CAMK2D | 1.38352847 |
15 | TAOK1 | 1.34523197 |
16 | MAP2K1 | 1.34474987 |
17 | STK24 | 1.30064323 |
18 | GRK6 | 1.29095177 |
19 | FGFR3 | 1.24086328 |
20 | MAP3K1 | 1.20143868 |
21 | MUSK | 1.19195023 |
22 | WNK4 | 1.18321234 |
23 | NLK | 1.18181095 |
24 | AKT3 | 1.12273877 |
25 | MAP3K12 | 1.08940559 |
26 | PTK2 | 1.05063251 |
27 | MAP3K11 | 1.04037513 |
28 | OXSR1 | 1.03986070 |
29 | DYRK1B | 1.01754553 |
30 | WNK3 | 1.01195964 |
31 | CASK | 0.98642229 |
32 | TYK2 | 0.95584140 |
33 | EPHA3 | 0.94043919 |
34 | MAP3K3 | 0.87913093 |
35 | MAP3K8 | 0.86803687 |
36 | TAOK2 | 0.86792125 |
37 | LMTK2 | 0.77565906 |
38 | GRK1 | 0.74109379 |
39 | ABL2 | 0.72751367 |
40 | MYLK | 0.71100783 |
41 | STK10 | 0.70665706 |
42 | MST4 | 0.68317019 |
43 | PDK1 | 0.64843961 |
44 | MAP2K3 | 0.61210529 |
45 | PRKCI | 0.58496233 |
46 | LATS1 | 0.55951122 |
47 | TESK1 | 0.53127984 |
48 | PRKG2 | 0.52970495 |
49 | CDC42BPA | 0.50245500 |
50 | RET | 0.49550390 |
51 | WNK1 | 0.48327970 |
52 | IRAK1 | 0.45119315 |
53 | TESK2 | 0.43994812 |
54 | BMPR2 | 0.43765086 |
55 | PRKCD | 0.42461195 |
56 | MELK | 0.41837829 |
57 | STK38L | 0.41289947 |
58 | EPHA2 | 0.41215139 |
59 | EPHB1 | 0.41136343 |
60 | ERN1 | 0.40781583 |
61 | PDGFRA | 0.40040997 |
62 | SGK223 | 0.39391558 |
63 | SGK494 | 0.39391558 |
64 | STK11 | 0.39137819 |
65 | STK39 | 0.38162987 |
66 | CDK9 | 0.37202927 |
67 | YES1 | 0.35852411 |
68 | BMX | 0.32591217 |
69 | EPHB2 | 0.32471966 |
70 | SRC | 0.32452755 |
71 | CHUK | 0.32295788 |
72 | ADRBK2 | 0.32046094 |
73 | TBK1 | 0.31915860 |
74 | SGK1 | 0.31633869 |
75 | PDK2 | 0.30413872 |
76 | PTK6 | 0.30170273 |
77 | PRKACA | 0.29850959 |
78 | TAOK3 | 0.28613218 |
79 | STK16 | 0.27723214 |
80 | MAPKAPK3 | 0.27636016 |
81 | STK38 | 0.26207735 |
82 | SGK2 | 0.25804043 |
83 | MAP4K1 | 0.25503728 |
84 | PRKCQ | 0.24004305 |
85 | CAMK2B | 0.23648486 |
86 | MAPK11 | 0.23430352 |
87 | EEF2K | 0.23270455 |
88 | IGF1R | 0.22928742 |
89 | BCKDK | 0.22802318 |
90 | JAK2 | 0.22438877 |
91 | PRKCA | 0.22366339 |
92 | CAMK2A | 0.22229428 |
93 | LYN | 0.22187999 |
94 | PRKCB | 0.22161036 |
95 | PRKG1 | 0.22131811 |
96 | PAK4 | 0.21601024 |
97 | MAPK15 | 0.21377730 |
98 | CDK6 | 0.21142134 |
99 | ZAK | 0.20567191 |
100 | SGK3 | 0.19920681 |
101 | STK3 | 0.18852623 |
102 | FGFR4 | 0.18699640 |
103 | ITK | 0.18326023 |
104 | CAMK2G | 0.17729907 |
105 | PAK2 | 0.16715180 |
106 | MARK3 | 0.14024283 |
107 | DDR2 | 0.13588140 |
108 | PIK3CG | 0.13337511 |
109 | MATK | 0.13200476 |
110 | CSK | 0.12266916 |
111 | PRKACG | 0.12143707 |
112 | PIM1 | 0.11360234 |
113 | KDR | 0.10812162 |
114 | DAPK3 | 0.10456495 |
115 | IKBKE | 0.09837048 |
116 | GSK3A | 0.09299181 |
117 | PRKCZ | 0.09035574 |
118 | RPS6KA1 | 0.09002084 |
119 | DMPK | 0.08526779 |
120 | MAPK4 | 0.08149580 |
121 | CSNK1E | 0.08056870 |
122 | TTN | 0.07381572 |
123 | PTK2B | 0.07112912 |
124 | FYN | 0.07031128 |
125 | LIMK1 | 0.06423390 |
126 | FER | 0.05980173 |
127 | MAP2K6 | 0.05573235 |
128 | RPS6KB2 | 0.05431235 |
129 | CSNK1A1 | 0.05420481 |
130 | ERBB4 | 0.05124133 |
131 | EPHA4 | 0.05068094 |
132 | ERBB2 | 0.04473630 |
133 | PDPK1 | 0.04037388 |
134 | PRKAA2 | 0.03439665 |
135 | MAP3K10 | 0.03009430 |
136 | ROCK2 | 0.02938669 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.53441775 |
2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 4.26868573 |
3 | Mineral absorption_Homo sapiens_hsa04978 | 3.61460956 |
4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.76084285 |
5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.73828930 |
6 | * Bile secretion_Homo sapiens_hsa04976 | 2.68366160 |
7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.68120083 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.32039343 |
9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.19062839 |
10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.13737126 |
11 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.08371065 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91854526 |
13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.80521039 |
14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75050105 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73688507 |
16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.68841972 |
17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.67904907 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.64430057 |
19 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.58006958 |
20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42321139 |
21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41021083 |
22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40235793 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.37274905 |
24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.33515542 |
25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32748114 |
26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31218125 |
27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30061853 |
28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28411888 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27259834 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25165825 |
31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22045295 |
32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17455801 |
33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.17245419 |
34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.14721563 |
35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14718459 |
36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12999847 |
37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.08430922 |
38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.07487261 |
39 | Tight junction_Homo sapiens_hsa04530 | 1.03472382 |
40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03431763 |
41 | Salivary secretion_Homo sapiens_hsa04970 | 1.00590235 |
42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98000395 |
43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95068380 |
44 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92662862 |
45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.92076373 |
46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91677660 |
47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91098018 |
48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90765238 |
49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87783767 |
50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.85422585 |
51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84573213 |
52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82575047 |
53 | Peroxisome_Homo sapiens_hsa04146 | 0.77860931 |
54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76417356 |
55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74673885 |
56 | Salmonella infection_Homo sapiens_hsa05132 | 0.74435486 |
57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74071321 |
58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72819474 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71910552 |
60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70228146 |
61 | ABC transporters_Homo sapiens_hsa02010 | 0.69333536 |
62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.68454964 |
63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67250495 |
64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66734727 |
65 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65549639 |
66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65405282 |
67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65000238 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64994626 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60627459 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.59569588 |
71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57195967 |
72 | Asthma_Homo sapiens_hsa05310 | 0.55410921 |
73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54395677 |
74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52073518 |
75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51248766 |
76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49815431 |
77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49688562 |
78 | Bladder cancer_Homo sapiens_hsa05219 | 0.48958431 |
79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47176936 |
80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45861713 |
81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45188886 |
82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45146652 |
83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.44366067 |
84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.44285027 |
85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43227253 |
86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41905316 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40884196 |
88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39989254 |
89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.39549856 |
90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.38718251 |
91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37861373 |
92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37561292 |
93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36497706 |
94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35363448 |
95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33479102 |
96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31894948 |
97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31523643 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.31193945 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29951965 |
100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29267345 |
101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27628388 |
102 | Prion diseases_Homo sapiens_hsa05020 | 0.26131491 |
103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24050617 |
104 | Allograft rejection_Homo sapiens_hsa05330 | 0.23467194 |
105 | Renin secretion_Homo sapiens_hsa04924 | 0.22184903 |
106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.21953462 |
107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.21478008 |
108 | Insulin resistance_Homo sapiens_hsa04931 | 0.20813635 |
109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20752101 |
110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20073012 |
111 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20011771 |
112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18907203 |
113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.17428868 |
114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15739423 |
115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08329551 |
116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.07327592 |
117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05370499 |
118 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03367306 |
119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.02477093 |
120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | -0.0674923 |
121 | Insulin secretion_Homo sapiens_hsa04911 | -0.0539322 |